Discussion page for Arch Therapeutics (ARTH)
by Lynn Clark, Stock Gumshoe | November 6, 2017 5:54 pm
This page is for discussion of Arch Therapeutics (ARTH)[1].
Endnotes:
- Arch Therapeutics (ARTH): https://www.stockgumshoe.com/tag/arth/
Source URL: https://www.stockgumshoe.com/2017/11/microblog-discussion-page-for-arch-therapeutics-arth/
Haven’t been here in a couple months and it seems nothing has changed. The stock hasn’t seen over 20 cents in a year and it is sitting today at 14 cents. About two months ago I saw a couple of other opportunities and I finally gave up and sold (forever) my shares in ARTH. It has been a long 5+ years and it is a shame this company was mismanaged so badly that a potentially good product that could have helped people may never see the light of day. Norchi is a joke. He has been happy to simply collect his paycheck every year from being the “CEO” of this company while never doing anything to get it into the hands of physicians. Many here are invoking Dr. KSS name and blaming him for this one. I think his only fault here is not foreseeing just how badly the company would be mismanaged. Hell, none of us did. He did however see a product that if managed correctly could have been big. Unfortunately we all AGAIN learned the pain that can often come with biotech investing. I’ll check in here from time to time but ARTH was really the main reason I came here in the past. For those still in it, I wish you the best and will still be rooting for you to find your islands! 🙂 Bonz……………. out.
I gave up recently and sold as well. I hope it didn’t hurt Cleveland too badly.
Cleveland has deep out of the money warrants which is why he kept pumping it on here to the detriment of others
Cleveland supposedly has deep out of the money warrants which is why he was on here pumping. Don’t feel bad
@Dr. Bonz I’m sorry to see you sell it all but thoroughly understand. I’ve been on the brink myself several times over. Maybe I hang on because I’ve enjoyed the really pleasant people that post on here (after the Dr KSS kerfuffle went away). Please do check in from time to time.
Yes, where are those buyers? If this is such a great product as it genuinely appears to be, why aren’t the big companies jostling elbows to get a chance to buy in, or take over?
The red numbers I see for the $ARTH losses have become familiar, and I’ve learned to live with them, but I do have sell orders sitting there for different levels of prices in different accounts.
I got fully out about a year ago. I had to sell off 3 million shares. The value of the Company is in the internal product. But by the time Norchi can get his stuff together to fund those very expensive trials…. Well there may be 700 million shares outstanding. Or many more. If he can even take it to fruition. Or find a sucker to buy it. Each share worth less then one sheet of a cheap single ply piece of TP. Norchi may have been good in his last job a million moons ago. But he is terrible at this. Throw him a curveball that you need to react to in real time and make important decisions… Well he is Elmer Fudd revisited. Get out while you still can. Eventually it might “hit”…. but at that point there may be a billion shares outstanding.
Makes no sense. Opportunity cost is a thing in the investment world
Intended for Dunny Dave who could make multiples on crypto platforms rather than wasting money on this
Hi Jeffrey! Got any good suggestions in the cryptocurrency arena? I’m willing to put some mad money there.
I would buy VET with lot of real world applications.
I took a hit on this stock. A big hit. But everything is relative. There were a few dumping in millions when it was at 50 cents. And now these people are in deep. Very deep. What do you do..? Cut your loss and take a huge hit or dump in a little more money in hopes you can re-coop your mistake.? Let us be thankful we are not in that position……
fi·du·ci·ar·y I had to look it up to spell it correctly but the concept does not escape me at all. One aspect of ARTH that puzzles me is the lack of offers to buy them out. Are the offers not being made public? ( I do not know how that would or should work) or does the medical device industry know something that we as investors do not ? Though these days I spend my time fishing and sailing for 20+ years prior to this bounty of free time, I spent my time as a corporate cog working in R&D much of it helping to develop wound care products. Something about ARTH and it’s stagnation does not add up. This situation seems to go beyond the pitfalls of investing in small bio companies .
You are right to point out that the situation is non-sensical, t34classic! While in my State of NY O&D’s do not have the usual fiduciary relationship to shareholders -(https://sahnward.com/eblasts/24174%20Fall%202011%20Newsletter/article2-fiduciary.html)- The path of these O&D’s, holding an effective and needed discovery is very odd indeed. You mentioned the word “stagnant” and that is a good description of the unexplained failure of AC-5 to progress toward buy-out or market. Common sense requires us to recognize that people usually act according to their own benefit. That leads us to ask how the O&D can benefit from this state of affairs? I will not explore that here because I am in possession of no facts to suggest how the O&D’s may benefit from the corporate failure/refusal to perform. Suggesting scenarios can be unfair or scandalous to the O&D’s. But, clearly, in the present posture, and in the absence of O&D providing any explanations, an investigation seems to be called for. However, such investigation can be thwarted if O&D’s hold 51% of the outstanding stock. Does anyone have those figures?
https://framinghamsource.com/index.php/2021/08/04/former-board-chair-charged-with-securities-fraud-conspiracy-obstruction/
Well… would ya look at that.
$arth
Thanks for posting…..
Great find. Always thought Norchi was a straight shooter up to a couple years ago. Having him as your Chairman? Gees oh man. ARTH will be sued into bankruptcy.
The fact both Avtar and Punit are both still holding positions in the company and are listed on the website is laughable.
Before I exited, I reached out to IR at Arch many times, never a peep. Should have seen the writing on the wall earlier.
They raise money, raise their salaries, don’t deliver, and repeat.
I’ve yielded more from a pint of Guiness than this proverbial mess.
My condolences go out to others who believed in the technology and invested their hard earned cash in hopes of bringing this technology to the forefront.
Your condolences received and appreciated, nocotek.
@Griffin I’m hanging on to $ARTH for now and will sell some before the end of the year to harvest losses for profit-offset purposes.
Unless anyone has any better ideas?
There’s always wall paper Penny. That’s what I’m saving mine for.
Regards,
Frank
Great find indeed, JMB44. Most interesting. How on earth was that information discovered?
Somewhere in the fairly recent past, someone here commented on Avtar Singh Dhillon’s being involved with $ARTH.
Is the problem Terri Norchi or the people around him, then it could be birds of a feather fly together. I’ve loss so much already there is no sense getting out.
Yes, he is considered innocent unless you have been a long term holder of ARTH shares!
Regards,
Frank
$ARTH
https://ir.archtherapeutics.com/press-releases/detail/562/arch-therapeutics-partners-with-lovell-government-services
$ARTH lqqkin’ at 11.5 cents. Who would of guessed it?
Great to see some familiar names here.
Hope all are well.
Best!
Same hopes for you too, Ben.
These days I worry that if I haven’t heard from someone for a year or so, that the Dreaded COVID might have got them.
$ARTH
Thanks Joe.
The sudden increase triggered a couple of my long-standing sell orders. Must look to see if I have harvested enough losses for 2021.
$ARTH still long but not quite so much
I’m still long as well. I figure I will ride this out since I’ve been in the stock for 6 years or so now. AC5 is an amazing product. I just hope it will finally be put to good use. Fingers crossed!
I sold my shares, needless to say at a lose a few months back. One of the things that pushed me over the edge was an interview with Norchi , he reminded me of a guy that would rather be home getting stoned and playing with the kids.
I saw the announcement that they had partnered an outfit to help deliver to the government, that’s nice about time, then I see the share price jump on volume and fall back, so I placed an order to sell at a penny and a half over 6, and it sold, I did keep about 20%.
Most recent news article from the company reports first product revenue to the VA, so this will be the first quarter with revenue, FINALLY. Most recent presentation on website https://content.equisolve.net/archtherapeutics/media/a42377743ede22713b8be5d34aee8966.pdfsays this is a “critical inflection point in commercialization plan”, on page 3. FINALLY!
The link works if you delete the s at the end of pdfs.
If you want to see the article, delete the s at the end of pdfs.
$ARTH
https://ir.archtherapeutics.com/press-releases/detail/571/arch-therapeutics-granted-federal-supply-schedule-and
joevan30000, thank you; finally some positive news. It really makes you wonder why they didn’t accomplish this a long time ago!
Regards,
Frank
Frank – you changed your name – almost didn’t recognize you! Or did you not log in?
Penny
You got me Penny, I didn’t log in. But I still remember you and Ben from a long time ago. I think you could refer to that as pre-KSS.
Regards,
Frank
You need to have those 1371 Thumbs Ups recognized, Frank!
And yes, pre-KSS – a long time ago for sure.
Do you think we’ll ever get to post-$ARTH?
We might Penny if they ever dump the CEO, Norchi.
Regards,
Frank
I agree Frank. I’m trying to stay positive. I’m hoping this is like the old Heinz ketchup, good things come to those who wait.
Hi Joe Van (or Jo Evan or Jo E Van) – I will admit to being baffled by your Heinz ketchup reference. What I think of with Heinz and my investments is “Biotech stocks – 57 different varieties of lost investment moneys” – with some exclusions, I’ll allow.
Yes, we $ARTH stock holders must stay positive. Hey good things! I’m here waiting!
Stay safe everyone,
Penny
Hi Penny, the Heinz reference is from a slogan on their tv advertising campaign from the late 1980s.
Thanks Joe – I barely watched TV back then being in the never-ending treadmill of working and raising children.
Just received a new research piece on $ARTH..
https://files.constantcontact.com/fdcb5758701/71e063f9-bb34-4315-81b4-085fb32a5c5e.pdf
I was getting my hopes up until I read the following in the report:
Financial risk. The company may need to raise capital in the marketplace relatively soon. There can be no assurance that the company will be able to raise capital and do so on favorable terms successfully.
I think we long-term holders are doomed!
$ARTH – management has been bilking its shareholder base every opportunity it gets. Black-tied scam masters who, if they don’t serve time, should be on everyone’s ‘short’ list for the next company they takeover and destroy.
Hey Mary!
Should we just sell up now, and instead of meeting at that private tropical island, meet up in Las Vegas and try our luck at the slot machines there? (after the pandemic is over, I mean.) I’m not bad at making my money last a pretty long time on the penny slots. Could we do worse?
Penny (still rather long $ARTH)
Mary, that language looks like boiler plate and has probably been on declaration they’ve made for years.
Regards,
Frank
“every declaration”
$ARTH latest news release
https://ir.archtherapeutics.com/press-releases/detail/573/clinical-evaluation-finds-arch-therapeutics-ac5
$3k in ‘goop’ revenue. Wow…
I think management could have yielded better by hopping over to the local burger joint and flipped fries for the quarter.
nocotek, my guess is you are spot on. ARTH has been void of revenue for so long they wouldn’t recognize it if they had any!
Regards,
Frank